Publication | Closed Access

Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways

Tumor BiologyOncologyMedicineCancer Cell BiologyColorectal CancerColorectal Cancer CellsTumor SuppressorAnti-cancer AgentAnti-tumor ActivityPharmacologyCell BiologyCancer ResearchOxidative Stress